I posted this in another thread but thought it was worth creating a new thread for. Just found this link to a new interview with Roger Aston discussing the Phase 2 Canine trial. He discusses the trial, clarifies 'stable disease', the Elanco option, human trials and more. Very much worth a watch. Brings me more confidence to hear it from him personally.
https://www.youtube.com/watch?v=73rIH2s5Tbg&feature=youtu.be
If link doesn't work, type "PharmAust (ASX PAA) Q&A" into YouTube by the channel "TechInvest Magazine"
Roger Aston Interview May 2020
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.015(7.89%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $129.6K | 653.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 119947 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 119150 | 7 |
View Market Depth
| Last trade - 15.59pm 09/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |